BROLUCIZUMAB for Polypoidal choroidal vasculopathy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 70 adverse event reports in the FDA FAERS database where BROLUCIZUMAB was used for Polypoidal choroidal vasculopathy.
Most Reported Side Effects for BROLUCIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Visual impairment | 116 | 17.0% | 0 | 7 |
| Vision blurred | 106 | 15.5% | 0 | 13 |
| Eye pain | 81 | 11.9% | 0 | 4 |
| Vitreous floaters | 74 | 10.9% | 0 | 2 |
| Vitritis | 65 | 9.5% | 0 | 4 |
| Ocular hyperaemia | 62 | 9.1% | 0 | 4 |
| Off label use | 62 | 9.1% | 3 | 1 |
| Subretinal fluid | 62 | 9.1% | 0 | 0 |
| Retinal vasculitis | 52 | 7.6% | 0 | 5 |
| Eye inflammation | 50 | 7.3% | 0 | 6 |
| Visual acuity reduced | 50 | 7.3% | 0 | 6 |
| Uveitis | 48 | 7.0% | 0 | 5 |
| Blindness | 44 | 6.5% | 0 | 4 |
| Product use in unapproved indication | 38 | 5.6% | 0 | 0 |
| Drug ineffective | 36 | 5.3% | 1 | 1 |
Other Indications for BROLUCIZUMAB
Neovascular age-related macular degeneration (225)
Choroidal neovascularisation (102)
Product used for unknown indication (85)
Age-related macular degeneration (73)
Diabetic retinal oedema (57)
Macular degeneration (34)
Retinal vein occlusion (29)
Diabetic retinopathy (6)
Other Drugs Used for Polypoidal choroidal vasculopathy
RANIBIZUMAB (315)
VERTEPORFIN (210)
AFLIBERCEPT (193)
BROLUCIZUMAB-DBLL (64)
BEVACIZUMAB (46)
FARICIMAB\FARICIMAB-SVOA (43)
FLUOROURACIL (17)
IRINOTECAN (17)
LEUCOVORIN (17)
LUCENTIS (7)